의약품 관련 법령
BfArM FAQs: On National Variation Notifications, Purely National Variation Procedures
작성자 | 관리자 | ||
---|---|---|---|
작성일 | 2018-07-18 | 조회수 | 634 |
국가정보 | 유럽>독일 | ||
출처 | BFARM | ||
원문 | www.bfarm.de | ||
첨부파일 |
BfArM FAQs: On National Variation Notifications, Purely National Variation Procedures
- 이전글 BfArM/PEI Announcement of 13-Jul-2018 on the Obligation to Notify a New Importation Country in Parallel Imported Medicinal Products According to § 29 of the German Drug Law (AMG)
- 다음글 Evaluation Report: Drug Approval Document of EVEROLIMO (Everolimus)